Company page

Curis, Inc.

Curis, Inc. (ticker: CRIS) is a public company based in the United States with a market capitalization of approximately $16.4 million. The company is focused on developing innovative treatments for cancer. Curis aims to advance its pipeline of drug candidates to address unmet medical needs in oncology.